Based on the new SF Cube technology platform, the BC-6800Plus could provide more reliable blood cell results and abnormal cells flagging results with anticipated warning messages, exceeding clinicians’ expectations and setting a new standard for blood analysis.
SF Cube Technology
With the newly designed opticals and reagent systems, the SF Cube technology can help doctors to better differentiate the clusters of cells, which is the key to revealing more abnormal cells.
NRBC result in every CBC
In WNB scattergram, BC-6800Plus provides NRBC, Basophils and WBC-N* results. It means that the actual number of NRBCs can be measured in routine CBC, if they are present in the sample.
Basophils are counted in this counting channel with NRBC results.
Basophil and NRBC results are generated on BC-6800Plus without extra reagent or cost.
NLR parameter in each CBC+DIFF
Neutrophil-to-lymphocyte ratio (NLR) is calculated by dividing neutrophil count by lymphocyte count, usually from peripheral blood sample.
In laboratory medicine, NLR is used as a marker of subclinical inflammation.
According to clinical studies, NLR can be used as a prognostic factor of severe illness in COVID-19 patients.
More accurate RET and PLT-O result
By utilizing the new fluorescent dye, the reticulocytes and platelets are more specific stained with stronger fluorescent signal, that brings more reliable reticulocyte and platelet results.